The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: levothyroxine     Quarter: 2016Q3

Total Records: 778     Number of Pages: 39

DRUGNAME PT EventCount
Levothyroxine Sodium Tablets, USP Pneumonia 3
Levothyroxine Sodium Tablets, USP Pyrexia 3
Levothyroxine Sodium Tablets, USP Rash erythematous 3
Levothyroxine Sodium Tablets, USP Rash papular 3
Levothyroxine Sodium Tablets, USP Rash pruritic 3
Levothyroxine Sodium Tablets, USP Renal failure 3
Levothyroxine Sodium Tablets, USP Respiratory disorder 3
Levothyroxine Sodium Tablets, USP Rhinitis allergic 3
Levothyroxine Sodium Tablets, USP Skin lesion 3
Levothyroxine Sodium Tablets, USP Skin ulcer 3
Levothyroxine Sodium Tablets, USP Tonsillar disorder 3
Levothyroxine Sodium Tablets, USP Type 2 diabetes mellitus 3
Levothyroxine Sodium Tablets, USP Visual acuity reduced 3
Levothyroxine Sodium Tablets, USP Wheezing 3
Levothyroxine Sodium Tablets, USP Wound 3
Levothyroxine Sodium Tablets, USP Wound infection 3
LEVOTHYROXINE SODIUM. Anaemia 3
LEVOTHYROXINE SODIUM. Anxiety 3
LEVOTHYROXINE SODIUM. Arteriosclerosis coronary artery 3
LEVOTHYROXINE SODIUM. Asphyxia 3

Total Records: 778     Number of Pages: 39